COPD News

This week, people with asthma not at higher risk for poor COVID-19 outcomes; adherence to asthma biologic therapy higher than inhaled corticosteroids; health care affordability, racial disparities persist in individuals with asthma, COPD; and more.

Health insurance coverage losses among patients with asthma and COPD improved after implementation of the Affordable Care Act, but there was no improvement in health care affordability or racial and economic disparities from 1997 to 2018.

The Healio Editors have compiled a list of the most-read news in pulmonology published in February.

A new study highlights age-specific differences in adherence to asthma and COPD medications, with the lowest adherence in young adults and the highest adherence in children and older adults.

Low FEV1/slow vital capacity in current and former smokers with normal spirometry may aid in the identification of individuals who are at increased risk for COPD, researchers reported in Chest.

Inhaled high-molecular-weight hyaluronan shortened the duration of respiratory failure and need for noninvasive ventilation in patients with acute exacerbation of COPD, according to results of a pilot study published in Respiratory Research.

The Healio editors have compiled a list of the most-read news in pulmonology published in January.

The Healio editors have compiled a list of the most-read COPD news published in 2020.

United States Preventive Services Task Force recommended that clinicians ask all adults about tobacco use and provide them with behavioral interventions and even FDA-approved pharmacotherapy to help them quit smoking.

Using a diagnostic algorithm, pulmonary embolism was detected in nearly 6% of patients hospitalized with COPD with acute worsening of respiratory symptoms, according to a study published in JAMA.